drugset / Trial / NCT03306615
Peripheral Modulation of Muscle Stiffness and Spasticity
Phase 2
Active not recruiting
56 enrolled
Johns Hopkins University
Sheikh Khalifa Stroke Institute · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a single-center, double-blind, randomized, placebo-controlled, sequential Phase II trial of human recombinant hyaluronidase injections in individuals with post-stroke upper limb muscle stiffness. The investigators will recruit 56 subjects, who will be randomized to receive either the intervention or normal saline injections (first injection), and then the intervention the participants did not receive first (second injection). All individuals will receive the treatment by the end of the study.
Timeline
- Start
- 2021-10-11
- Primary completion
- 2026-06-26
- Completion
- 2027-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rHuPH20 | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.